Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Revenue: 2021-2024

Historic Revenue for Kiniksa Pharmaceuticals International (KNSA) over the last 4 years, with Dec 2024 value amounting to $423.2 million.

  • Kiniksa Pharmaceuticals International's Revenue rose 61.17% to $180.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $598.0 million, marking a year-over-year increase of 55.68%. This contributed to the annual value of $423.2 million for FY2024, which is 56.60% up from last year.
  • Latest data reveals that Kiniksa Pharmaceuticals International reported Revenue of $423.2 million as of FY2024, which was up 56.60% from $270.3 million recorded in FY2023.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Revenue ranged from a high of $423.2 million in FY2024 and a low of $10.0 million during FY2022.
  • For the 3-year period, Kiniksa Pharmaceuticals International's Revenue averaged around $234.5 million, with its median value being $270.3 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first crashed by 74.06% in 2022, then spiked by 2,602.59% in 2023.
  • Over the past 4 years, Kiniksa Pharmaceuticals International's Revenue (Yearly) stood at $38.5 million in 2021, then plummeted by 74.06% to $10.0 million in 2022, then soared by 2,602.59% to $270.3 million in 2023, then soared by 56.60% to $423.2 million in 2024.